Biohaven
(NYSE) BHVN
Biohaven Financials at a Glance
Market Cap
$2.31B
Revenue (TTM)
$0.00
Net Income (TTM)
-$647.68M
EPS (TTM)
-$5.67
P/E Ratio
-2.71
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$15.78
Volume
9,513,017
Open
$15.71
Price
$15.78
Volume
9,513,017
Open
$15.71
Previous Close
$15.83
Daily Range
$15.45 - $16.74
52-Week Range
$7.48 - $18.57
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$15.78
Volume
9,513,017
Open
$15.71
Previous Close
$15.83
Daily Range
$15.45 - $16.74
52-Week Range
$7.48 - $18.57
Estimated Earnings Date
Aug 10, 2026
BHVN News
BHVN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biohaven
Industry
Biotechnology
Sector
Health CareEmployees
274
CEO
Vladimir Coric, MD
Website
www.biohaven.comHeadquarters
New Haven, CT 06510, US
BHVN Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-866.46%
Return on Capital
-221.39%
Return on Assets
-138.87%
Earnings Yield
-36.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.31B
Shares Outstanding
150.56M
Volume
9.51M
Avg. Volume
2.62M
Financials (TTM)
Gross Profit
-$2.07M
Operating Income
-$654.25M
EBITDA
-$638.55M
Operating Cash Flow
-$594.23M
Capital Expenditure
-$254.00K
Free Cash Flow
-$594.49M
Cash & ST Invst.
$347.82M
Total Debt
$286.18M
Biohaven Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.31B
N/A
Market Cap/Employee
$9.02M
N/A
Employees
256
N/A
Net Income
-$130.53M
+41.1%
EBITDA
-$127.89M
+41.6%
Quarterly Fundamentals
Total Cash
$347.82M
+7.8%
Total Debt
$286.18M
+705.9%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$280.28M
+809.9%
Short Term Debt
$5.90M
+25.3%
Return on Assets
-1.39%
N/A
Return on Invested Capital
-1.58%
N/A
Free Cash Flow
-$149.92M
+9.5%
Operating Cash Flow
-$149.92M
+9.2%